1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Market: By Product (Recombinant Glycosated Proteins, Others) Technology (Chromatography, Mass Spectroscopy, Electrophoresis, Others) Application (Blood & Oncology Diseases, Chronic Diseases, Growth hormone deficiency, Others)-Forecast(2015-202

Biosimilars Market: By Product (Recombinant Glycosated Proteins, Others) Technology (Chromatography, Mass Spectroscopy, Electrophoresis, Others) Application (Blood & Oncology Diseases, Chronic Diseases, Growth hormone deficiency, Others)-Forecast(2015-202

  • August 2015
  • -
  • Industry ARC
  • -
  • 86 pages

Summary

Table of Contents

BioSimilar is a bio pharmaceutical drug that have similar property to the drug previously licensed. As the number of diseased people increase, the demand for cheaper drugs also increase leading to increase in biosimilars market.

The global market for the biosimilars is segmented into different product types by technology and application. Each of these segmentations has been further broken down into the sub segments to give an in-depth and comprehensive analysis of biosimilars market

Regulations for biosimilars play a vital role as they maintain a balance between original & biosimilar products. Currently the geographic biosimilar market is segmented into Americas, Europe, APAC and rest of the world.

Some of the key players included in the report are:
Novaritis (Sandoz)
Hospira
Glaxo Smith Kline
Pfizer
Teva
Biocon
Ranbaxy.

Please note: this report requires certain updates. We have all the information available but require 2 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Biosimilars Market, Europe, Forecast to 2025

Biosimilars Market, Europe, Forecast to 2025

  • $ 4950
  • Industry report
  • March 2017
  • by Frost & Sullivan

A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter Patent expiration and increased use of traditional generic drugs are leading to a ...

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022

  • $ 4550
  • Industry report
  • January 2017
  • by Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.